CareDx, Inc
CDNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.4% | 2.4% | -2.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.7% | 66.9% | 66.4% | 67.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Income | $0 | -$0 | -$0 | $0 |
| % Margin | 2% | -12.8% | -15.8% | 86.3% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | -$0 | -$0 | $0 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 1.7% | -9.9% | -12.2% | 90.1% |
| EPS | 0.03 | -0.16 | -0.19 | 1.62 |
| % Growth | 118.8% | 15.8% | -111.7% | – |
| EPS Diluted | 0.03 | -0.16 | -0.19 | 1.51 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 6.8% | -6.6% | -3.6% | -17.6% |